Cover storyContinued Process Verification In Pharma: What Literature Shows
CPV theory is well understood, but literature shows execution is uneven, here's what real-world data reveals about running Stage 3 well.
Cover storyCPV theory is well understood, but literature shows execution is uneven, here's what real-world data reveals about running Stage 3 well.

FDA issues immediate compounding guidance after two outsourcing facility shutdowns create a neonatal parenteral nutrition supply gap.

Novartis pelacarsen fails Lp(a)HORIZON Phase III primary endpoint in 8,323 patients, raising ASO manufacturing and Ionis collaboration capacity questions.

FDA grants AstraZeneca accelerated approval for camizestrant in ESR1-mutation breast cancer, the first ctDNA resistance-guided oncology approval.

FDA grants accelerated approval to AstraZeneca's camizestrant with a CDK4/6 inhibitor for ESR1-mutated HR+/HER2- metastatic breast cancer, tied to Guardant360 CDx companion diagnostic.
Latest edition

Sep 28
Oct 06From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
